Besides chairing Cytomed, Choo is also the long-time vice chairman of SGX-listed CNMC Goldmine Holdings.
CytoMed Therapeutics, a Singapore-based pre-revenue biomedical firm backed by Peter Choo, has listed on the Nasdaq.
Choo, a renowned figure in the local corporate scene, was once dubbed "IPO King" for shepherding dozens of listings on the local bourse when he was running Westcomb Securities
